Blog
RSS FeedPosted by Michael Wonder on 02 Nov 2025
The slow-release dose
31 October 2023 - Canadians wait years for new drugs, even those already deemed safe, because public funding takes longer to ...
Posted by Michael Wonder on 02 Nov 2025
DoH publishes revised agenda for November 2025 PBAC meeting (version 6)
31 October 2025 - The DoH has published a revised agenda for the November 2025 PBAC meeting. ...
Posted by Michael Wonder on 01 Nov 2025
Elahere receives positive reimbursement recommendation by Canada's Drug Agency for certain types of platinum-resistant ovarian cancers
30 October 2025 - Elahere was submitted for reimbursement review 180 days prior to Health Canada's approval in line with ...
Posted by Michael Wonder on 31 Oct 2025
New Zealand Pharmaceutical Schedule - 1 November 2025
1 November 2025 - The November 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2025
Schedule of Pharmaceutical Benefits - 1 November 2025
1 November 2025 - The November 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Oct 2025
Public Summary Documents – July 2025 PBAC meeting
31 October 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2025 PBAC ...
Posted by Michael Wonder on 31 Oct 2025
NICE’s backing of the prostate cancer drug abiraterone could help thousands and save the NHS millions
30 October 2025 - Today we’ve published final draft guidance recommending abiraterone and its generic variants in combination with androgen ...
Posted by Michael Wonder on 28 Oct 2025
Cheaper medicine for kidney disease patients
28 October 20925 - Tens of thousands of Australians living with chronic kidney disease will soon have access to more ...
Posted by Michael Wonder on 27 Oct 2025
Chronic kidney treatment made cheaper for people like Franki
28 October 2025 - A diabetes drug that helps to slow kidney damage will be made available to more people ...
Posted by Michael Wonder on 27 Oct 2025
Long-lasting contraceptive gets new PBS listing
26 October 2025 - Women will be given more birth control choices from Saturday with a monthly vaginal ring, which can ...
Posted by Michael Wonder on 27 Oct 2025
Delivering better access to contraception for Australian women
27 October 2025 - Australian women will soon have better access to affordable contraceptive options thanks to the Australian Government’s ...
Posted by Michael Wonder on 24 Oct 2025
Up to 6,000 patients to benefit from NICE-approved life-extending prostate cancer drug
24 October 2025 - People living with metastatic prostate cancer in England will gain access to a new treatment combination from ...
Posted by Michael Wonder on 23 Oct 2025
New life saving medicine free for rare disease
22 October 2025 - Australians with the extremely rare and life-threatening inherited disease, acid sphingomyelinase deficiency (ASMD) will now have ...
Posted by Michael Wonder on 22 Oct 2025
Updated information about Pharmac’s priority lists (September 2025)
21 October 2025 - Pharmac’s Pūahoaho Report provides the latest information about applications for medicines, vaccines, and related products that we’ve ...
Posted by Michael Wonder on 22 Oct 2025
Sarilumab for the treatment of children/adolescents 2-17 years of age with polyarticular or oligoarticular juvenile idiopathic arthritis
22 October 2025 - NICE is unable to make a recommendation on the use of sarilumab (Kevzara) for the treatment of ...